Skip to main content
. Author manuscript; available in PMC: 2021 May 5.
Published in final edited form as: Aging Ment Health. 2019 Jul 10;24(12):1956–1962. doi: 10.1080/13607863.2019.1639136

Table 1.

Totals and comparison of robust vs. pre-frail/frail participants.

Variables Total Robust Pre-frail/frail
N 146 74 72
Socio-demographics
 Age** 81.62 (6.14) 79.18(5.40) 84.13 (5.86)
 Caucasian 131 (92.9) 65 (92.9) 66 (92.96)
 Female 110 (75.3) 57 (77.0) 53 (73.6)
 Education 17.05 (3.12) 17.30 (3.07) 16.80 (3.17)
Medical history
 Co-morbidities compositea** 10.68 (5.06) 8.53 (3.80) 12.90 (5.25)
 Tobacco use 65 (46.4) 27 (38.0) 38 (55.1)
 Body mass index 27.16 (5.38) 26.62 (4.48) 27.72 (6.16)
 Heart rate* 68.04 (7.88) 66.63 (7.33) 69.34 (8.19)
Psychosocial factors
 Depression Score* 3.78 (3.51) 2.78 (2.53) 4.81 (4.06)
 Coping self-efficacy, N high SE* 129 (88.4) 70 (94.6) 59 (81.9)
 Self-efficacy of chronic disease management, N high SE* 130 (89.0) 70 (94.6) 60 (83.3)
 Social support 24.25 (4.68) 24.23 (4.65) 24.26 (4.75)
 Perceived stress 2.36 (0.28) 2.36 (0.27) 2.36 (0.29)
 Life events* 85.02 (68.31) 72.26 (64.98) 98.14 (69.60)
 Illness intrusiveness** 21.83 (13.01) 17.41 (10.31) 26.32 (13.96)
 Financial strain, N w/strain 16 (11.03) 8 (10.81) 8 (11.27)

Note: Values displayed as means (SD) for continuous variables and total numbers (percent of total) for categorical variables. SD, standard deviation; SE, self-efficacy.

a

Composite score of disease count, treatment count and functional limitations.

*

p < 0.05 for significant difference between the robust and prefrail/frail groups.

**

p < 0.0001 for significant difference between the robust and prefrail/frail groups.